biotech
biotech Articles
Ahead of election years, the cost and future of health care has become one of the top debates for better than two decades now. Most politicians say that they want to lower prescription drug costs....
Published:
Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch for in early 2020.
Published:
Innate Pharma shares jumped on Thursday after the firm announced that the European Medicines Agency has accepted the Marketing Authorization Application for Lumoxiti for adult patients with relapsed...
Published:
Neovasc shares nearly doubled on Tuesday after the firm announced the submission of an application to the FDA for its Neovasc Reducer medical device for the treatment of refractory angina.
Published:
Wave Life Sciences shares dropped sharply to start out the week after the company announced topline data from its ongoing midstage trial in Huntington’s disease.
Published:
Sarepta shares jumped last week on news that the company reached a licensing deal with Roche. While investors saw about a five-point bump from this news, one analyst sees much more upside for this...
Published:
Savara shares more than doubled on Monday after the firm announced that the FDA has granted Breakthrough Therapy designation for its autoimmune pulmonary alveolar proteinosis treatment Molgradex.
Published:
Iterum Therapeutics shares more than doubled on Friday after the firm announced that it had completed the enrollment of its late-stage clinical trial in uncomplicated urinary tract infections.
Published:
Flexion Therapeutics shares popped on Friday after the company announced that the FDA has approved a supplemental New Drug Application to update the product label for Zilretta for the treatment of...
Published:
Immunomedics shares made a handy gain on Thursday after the company announced that the FDA has accepted its Biologics License Application for its breast cancer treatment.
Published:
Spectrum Pharma shares were halved on Thursday after the firm provided an update on its midstage cancer study some updates on its late-stage programs with the FDA.
Published:
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
NewLink Genetics shares jumped on Tuesday after the company announced that it entered into an exclusive worldwide license agreement with Ellipses Pharma.
Published:
Here, 24/7 Wall St. has included a calendar of a few of the biggest clinical trial and FDA updates to watch for going into 2020.
Published:
Sarepta Therapeutics shares made a handy gain to start the week after it announced a licensing agreement with Roche for its investigational gene therapy for Duchenne muscular dystrophy.
Published: